Retraction
MiR-375 Impairs Breast Cancer Cell Stemness by Targeting the KLF5/G6PD Signaling Axis
Paper Information
Record ID:
62209
Author(s):
Journal:
Publication Date:
March 12, 2024
Retraction Date:
February 17, 2025
(<1 year years ago)
Subjects:
Institutions:
- School of Life Science and Technology, ChinaPharmaceutical University, Nanjing, China
- Department of Pharmacy, ZhejiangPharmaceutical University, Ningbo, People'sRepublic of China
- Department of Anesthesiology, HepatobiliarySurgery, Neonatology, The First AffiliatedHospital of Xinxiang Medical University, WeiHui, China
- Department of Pharmacy, The AffiliatedCancer Hospital of Zhengzhou University &Henan Cancer Hospital, Zhengzhou, People'sRepublic of China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Elsevier
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (4)
4
Total Citations1
Post-Retraction(25.0%)
2
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
72
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Regulation of Different Types of Cell Death by Noncoding RNAs: Molecular Insights and Therapeutic Implications
Rajni Kumari, Satarupa Banerjee
ACS Pharmacology & Translational Science
Published: Apr 2025
72 days after retraction
Significance of Malic Enzyme 1 in Cancer: A Review
Rina Fujiwara‐Tani, Chie Nakashima, Hitoshi Ohmori et al. (8 authors)
Current Issues in Molecular Biology
Open Access
Published: Jan 2025
19 days before retraction
Targeting purine metabolism-related enzymes for therapeutic intervention: A review from molecular mechanism to therapeutic breakthrough
Di Wu, Shengqiang Yang, Chenyang Yuan et al. (8 authors)
International Journal of Biological Macromolecules
Published: Oct 2024
9 citations
9 citations
139 days before retraction
Quick Stats
Total Citations:
6
Years Since Retraction:
<1 year
Open Access:
Yes
Last Checked:
Jul 23, 2025